Alcohol, universal inhibition unburdener and ubiquitous recreational drug extraordinaire, is a substance we all would love to hate, if only it didn’t go so damn well with everything from bars to ball-games to back-yard cook-outs—and just about everything in between. So just what is the health and body composition conscious drinker to do? Tee-totaling is clearly no fun, and also tends to summon the awkward “so what’s your deal?” Rather, moderation and ‘picking your battles’ (or maybe just blackouts) seems to be the better course of action. But is there anything else one can do to decrease the damage to ones’ liver and leanness so common with ethanol-indulgence?
You bet your bottom dollar-draft there is, and its name is Sesathin™.
Sesathin™, a naturally-occurring, damn-near-miracle sesame lignan, is pretty much damage control in a pill (or liquid lecithin suspension) from all the chief metabolic harms of cocktail hour. How so you ask? Well, let’s break it down then.
Alcohol, also known as ethanol, is a nutritively dense substance that provides 7.1 calories per gram (1), almost twice that of a gram of protein or carbohydrate. Considering most drinks contain roughly 12g of ethanol, you’re looking at about 84kcals from the alcohol content alone in your average drink. Obviously, if you’re drinking a beer or sipping a Mai Tai, you’re going to have to factor in some carb-calories too (and don’t even get me started on Orgasms and White Russians). And generally, once you pop a shot, the fun don’t stop until you’ve put down easily five hundred to a thousand-plus calories—not exactly ideal if you’re watching your waistline, particularly if you’re a frequent (we call them “recreational”) drinker. Even if we grant the Microsomal Ethanol Oxidizing System and the other systems in the body that metabolize alcohol some degree of inefficiency, alcohol is definitely not giving you a free-ride calorically (2,3,4).
Moreover, alcohol’s chief metabolic byproduct, acetate, will directly suppress fat-oxidation in the short-term (5,6). Even worse perhaps, is research showing that alcohol consumption not only directly increases fat storage via a modest activation of the hepatic de novo lipogenesis pathway (5,7), but likely also increases adipogenesis (the creation of fat cells) from stem cells through an upregulation of PPARgamma2 (8). All told, acute ethanol intake in humans has been shown to reduce whole-body lipid-oxidation by a whopping 73%, while systematic lipolysis is virtually halved (5). Couple that with upregulated fat-storage potential, a whopping increase in cortisol secretion (9,10), temporary insulin resistance which is then compensated for by a resultant hypersecretion of insulin (11), acute hypertriglyceridemia (12,13) and a 3 a.m. trip to Wendy’s because dude, you’re starving, and unless you’ve got miracle genetics, your abs are going to be looking to duck and cover from your lifestyle under a nice layer of stored lipids.
Unfortunately, the ills don’t exactly end there with alcohol. High levels of consumed alcohol will also cause a build-up of toxic (and reactant) metabolic intermediates like acetaldehyde from the alcohol dehydrogenase reaction (14), metabolic acidosis (15), and the inhibition of hepatic (liver) fatty acid metabolism because of a heightened demand for NAD+ (16,17), which often results in the detrimental accumulation of fatty acids (fatty) liver (18) and heightened VLDL (19,20). Generally, liver enlargement and fatty-acid buildup can be reversed once the alcohol is withdrawn (17). All the same, if one’s consumption is frequent enough, the resultant cell death and inflammation from these hepatic alterations can develop into full-blown and occasionally fatal clinical conditions like alcoholic hepatitis or cirrhosis of the liver (21,22). Finally, if I haven’t already brought my health-conscious drinking audience to the verge of tears, alcohol is also immunosuppressive (23,24), as the ingestion of ethanol blunts the body’s ability to properly produce IL-1, IL-6, and TNF-alpha (24) and antigen specific T-cells (25), two critical facets to the body’s immune response (26).
As you can plainly see, Sesathin clearly has its work cut out for it. Luckily for us however, it rises to the challenge admirably, combating the negative effects of alcohol through numerous pathways.
We first talked about body composition, where Sesathin truly shines as a dietary supplement. Alcohol drops the body’s fatty-acid oxidation rates by 73%? Well, Sesathin’s potent PPARalpha activation (the same mechanism that the omega-3 fatty acids in fish oil work through, only far stronger) increases fat-oxidation 10-fold over baseline in skeletal muscle (27). Even better, it has similar properties in the liver, where it markedly decreases triglyceride (TG) formation and increases TG uptake and fatty acid oxidation (27,28,29). As mentioned earlier, alcohol’s ability to blunt fat oxidation and cause the accumulation of fatty acids in the liver are two of its worst side-effects, and Sesathin directly antagonizes both. In fact, whereas the upregulation of PPARgamma (in this case by ethanol) strongly promotes fat gain, the upregulation of PPARalpha-mediated gene-expression does the exact opposite in the body: it promotes leanness, accelerates fat metabolism, and decreases fat storage (30,31,32).
But Sesathin’s ownage of alcohol-prompted pathologies goes even further, thanks to its strong anti-oxidant, anti-inflammatory, blood-lipid improving, and insulin-sensitizing properties. Alcohol increases oxidative stress and causes the build-up of toxic metabolites. Sesathin decreases oxidative stress and inhibits the metabolism of the anti-oxidant/anti-inflammatory compound vitamin E (33,34,35,36). In fact, the actives in Sesathin have been clinically proven to protect the liver from damage induced by both the toxic chemical carbon tetrachloride, and, you guessed it, alcohol overdose (37).
Additionally, the ingredients in Sesathin positively modulate insulin sensitivity and blood lipid levels (27,35), a dynamic which ought to seriously come in handy against the insulin resistance and hyperlipidemia so commonly seen with ethanol ingestion in humans. Plus, Sesathin’s anti-inflammatory, PPARalpha activating, and phospholipid membrane-permeating properties will also put a check on increases in inflammatory cytokines and the formation of the prostaglandin PGE2. This means that Sesathin will also help counteract the immunosuppressive effects of alcohol, and should theoretically boost immune-function, even during and after inebriation. And, in what seems like a gift from above, Sesathin may even decrease hangovers, since it antagonizes the very inflammatory prostaglandins that ethanol consumption has been shown to increase (38). Anybody know why popping Aspirin like Skittles is like, “Hangover Home-Remedies 101” for anybody who hit the bar a little too hard the night before? Because Aspirin is a non-steroidal anti-inflammatory (NSAID) drug that inhibits the formation of those same inflammatory prostaglandins known for contributing to soreness and headaches. How glorious is that??
So the next time you decide to go bottoms up, don’t forget your Sesathin™, easily the best all-in-one protective against the ills of intoxication since M.A.D.D. Don’t forget to drink responsibly. Cheers all.
1. Schutz Y. Role of substrate utilization and thermogenesis on body-weight control with particular reference to alcohol. Proc Nutr Soc 2000 Nov;59(4):511-7
2. Atwater WO, Benedict FG. An experimental inquiry regarding the nutritive value of alcohol. Mem Nat Acad Sci 1902; 8: 235-295
3. Prentice AM. Alcohol and obesity. Int J Obes Relat Metab Disord 1995 Nov;19 Suppl 5:S44-50
4. Suter PM, Schutz Y, Jequier E. The effect of ethanol on fat storage in healthy subjects. N Engl J Med 1992 Apr 9;326(15):983-7
5. Siler S et al. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. American Journal of Clinical Nutrition, Vol. 70, No. 5, 928-936, November 1999
6. Woollett L et al. Adaptation of lipogenesis and lipolysis to dietary ethanol. Alcohol Clin Exp Res. 1987 Aug;11(4):336-9.
7. Brunengraber H, Boutry M, Lowenstein L, Lowenstein JM. The effect of ethanol on lipogenesis by the perfused liver. In: Thurman RG, Yonetani T, Willimason JR, Chance B, eds. Alcohol and aldehyde metabolizing systems. New York: Academic Press, 1974:329–37.
8. Wezeman FH, Gong Z. Adipogenic Effect of Alcohol on Human Bone Marrow-Derived Mesenchymal Stem Cells. Alcohol Clin Exp Res. 2004 Jul;28(7):1091-1101.
9. Valimaki MJ, Harkonen M, Eriksson CJ, Ylikahri RH. Sex hormones and adrenocortical steroids in men acutely intoxicated with ethanol. Alcohol 1984 Jan-Feb;1(1):89-93
10. Koziris LP, Kraemer WJ, Gordon SE, Incledon T, Knuttgen HG. Effect of acute postexercise ethanol intoxication on the neuroendocrine response to resistance exercise. J Appl Physiol 2000 Jan;88(1):165-72
11. Shelmet J et al. Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. J Clin Invest. 1988 Apr;81(4):1137-45.
12. Nestel PJ, Hirsch EZ. Mechanism of alcohol-induced hypertriglyceridemia. J Lab Clin Med 1965;66:357–65
13. Avogordo P et al. Changes in the composition and physico-chemical characteristics of serum lipoproteins during ethanol-induced lipaemia in alcoholic subjects. Metabolism. 1975 Nov;24(11):1231-42.
14. Gershman H. Acetaldehyde-ethanol exchange in vivo during ethanol oxidation. Arch Biochem Biophys. 1975 May;168(1):327-30.
15. Halpernin M et al. Metabolic acidosis in the alcoholic: a pathophysiologic approach. Metabolism. 1983 Mar;32(3):308-15.
16. Jones DP, Perman ES, Lieber CS. Free fatty acid turnover and triglyceride metabolism after ethanol ingestion in man. J Lab Clin Med 1965; 6:804–13.
17. Lieber CS, Schmid R. The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro. J Clin Invest 1961; 40:394–9.
18. Wiebe T, Lundquist A, Belfrage P. Time-course of liver fat accumulation in man after a single load of ethanol. Scand J Clin Lab Invest 1971;27:33–6.
19. Siler SQ, Neese RA, Parks EJ, Hellerstein MK. VLDL-triglyceride production after alcohol ingestion, studied using [2-13C1]glycerol. J Lipid Res 1998;39:2319–28
20. Taskinen MR, Valimaki M, Nikkila EA, Kuusi T, Ylihahri R. Sequence of alcohol-induced initial changes in plasma lipoproteins (VLDL and HDL) and lipolytic enzymes in humans. Metabolism 1985;34:112–9
21. R. G. Thurman Mechanisms of Hepatic Toxicity II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin Am J Physiol Gastrointest Liver Physiol 275: G605-G611, 1998
22. Kurose I et al. Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. Hepatology, 1997; Vol. 25:2, pp.368-378.
23. Nelson S, Bagby GJ, Bainton BG, Summer WR. The effects of acute and chronic alcoholism on tumor necrosis factor and the inflammatory response. J Infect Dis 1989 Sep;160(3):422-9
24. Szabo G, Mandrekar P, Girouard L, Catalano D. Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production. Alcohol Clin Exp Res 1996 Aug;20(5):900-7
25. de Waal Malefyt R, Yssel H, de Vries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993 Jun 1;150(11):4754-65
26. Nacy CA, Meierovics AI, Belosevic M, Green SJ. Tumor necrosis factor-alpha: central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathobiology 1991;59(3):182-4
27. Takashi I et al. Sesathin, a sesame lignan, as a potent serum lipid-lowering food component. JARQ, 2003, 37(3); pp.151-158.
28. Ashakumary L, Rouyer I, Takahashi Y, Ide T, Fukuda N, Aoyama T, Hashimoto T, Mizugaki M, Sugano M. Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism. 1999 Oct;48(10):1303-13.
29. Ide T, Ashakumary L, Takahashi Y, Kushiro M, Fukuda N, Sugano M. Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta. 2001 Nov 30;1534(1):1-13.
30. Gulick, T, Cresci S, Caira T, Moore DD, and Kelly DP. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 91: 11012-11016, 1994
31. Kliewer, SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, Devchand P, Wahli W, Willson TM, Lenhard JM, and Lehmann JM. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94: 4318-4323, 1997
32. Leone, TC, Weinheimer CJ, and Kelly DP. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 96: 7473-7478, 1999
33. Fukuda Y, Nagata T, Osawa T, Namiki M. Contribution of lignan analogues to antioxidative activity of refined unroasted sesame oil. J Am Oil Chem Soc 1986;63:1027–31.
34. Utsunomiya T et al. Effects of sesamin-supplemented dietary fat emulsions on the ex vivo production of lipopolysaccharide-induced prostanoids and tumor necrosis factor alpha in rats. American Journal of Clinical Nutrition 2000, Vol. 72, No. 3, 804-808
35. Sugano M, Akimoto K. Sesamin: a multifunctional gift from nature. J Chin Nutr Soc 1993;18:1–11.
36. Hemalatha S, Raghunath M, Ghafoorunissa. Dietary sesame oils inhibits iron-induced oxidative stress in rats [corrected] Br J Nutr. 2004 Oct;92(4):581-7.
37. Akimoto K, Kitagawa Y, Akamatsu T, Hirose N, Sugano M, Shimizu S, Yamada H. Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann Nutr Metab. 1993;37(4):218-24.
38. Manku MS, Oka M, Horrobin DF. Differential regulation of the formation of prostaglandins and related substances from arachidonic acid and from dihomogammalinolenic acid. I. Effects of ethanol. Prostaglandins Med 1979 Aug;3(2):119-28